Cargando...
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
BACKGROUND: Therapies for metabolic diseases are numerous, yet improving insulin sensitivity beyond that induced by weight loss remains challenging. Therefore, search continues for novel treatment candidates that can stimulate insulin sensitivity and increase weight loss efficacy in combination with...
Gardado en:
| Publicado en: | Mol Metab |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8085567/ https://ncbi.nlm.nih.gov/pubmed/33166741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2020.101109 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|